Additionally, we analyzed the sensitivity of MCM2 to anticancer drugs in various cancers by using genomics of drug sensitivity, which indicated that MCM2 could serve as potential biomarkers for drug screening and affect clinical responses to treatment. Here, MCM2 is linked to cancer.